Markets:

Overview

News

Currencies

International

Treasuries

Jazz Pharmaceuticals plc - Ordinary Shares (NQ:JAZZ)

136.71 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Nov 12, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Jazz Pharmaceuticals plc - Ordinary Shares

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Recap: Jazz Pharmaceuticals Q2 Earnings ↗

August 03, 2021

Shares of Jazz Pharmaceuticals (NASDAQ:JAZZ) decreased in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 5.12% over the past...

Via Benzinga

Attention Biotech Investors: Mark Your Calendar For August PDUFA Dates ↗

August 02, 2021

The month of July was disappointing from the perspective of Food and Drug Administration decisions, as the agency handed down mostly negative verdi...

Via Benzinga

Jazz Pharmaceuticals's Earnings: A Preview ↗

August 02, 2021

Jazz Pharmaceuticals (NASDAQ:JAZZ) releases its next round of earnings this Tuesday, August 03. Get the latest predictions in Benzinga's essential guide to the company's Q2...

Via Benzinga

Does Big Business Provide A Better Look Into Cannabis Reform Than Capitol Hill? Operators Believe So. ↗

July 29, 2021

Cannabis operators and executives tell Benzinga that the movement of private and public companies may serve as a better indicator of regula...

Via Benzinga

Topics Cannabis

Where Jazz Pharmaceuticals Stands With Analysts ↗

June 22, 2021

Within the last quarter, Jazz Pharmaceuticals (NASDAQ:JAZZ...

Via Benzinga

Is Jazz Pharmaceuticals Stock a Buy? ↗

July 24, 2021

Jazz Pharma is not the most popular drugmaker, but it is definitely worth a second look.

Via The Motley Fool

The Week In Cannabis: Justice Clarence Thomas, Mexico's Decriminalization, Apple's Policy Changes, Tilray And More ↗

July 02, 2021

Below is a recap of the main news related to the cannabis industry and markets for the week of June 28, 2021. Justice Thomas&nbs...

Via Benzinga

Topics Cannabis

Global Cannabis Stocks Decline 8.7% in Q2, Agrify, KushCo Among Strongest Cannabis Names In June ↗

July 02, 2021

The Global Cannabis Stock Index fell for the fourth straight month, dropping 4.1% to 57.10. During the second quarter, the index was down...

Via Benzinga

Topics Cannabis

The Daily Biotech Pulse: Spero Spikes On Pfizer Investment, FDA Nod For Jazz, Orchard Signs Licensing Deal, Acumen Pharma Debuts ↗

July 01, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 30) Ambrx Biopharma Inc. (NYSE...

Via Benzinga

Jazz Pharma's Rylaze Scores FDA Approval For Blood Cancer ↗

July 01, 2021

The FDA has approved Jazz Pharmaceuticals plc (NASDAQ: JAZZ) Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) for the treatment of acute lymphoblastic...

Via Benzinga

Got $5,000? These 3 Stocks Are Ridiculously Cheap Buys ↗

June 29, 2021

They are great options whether you are investing for the short or long term.

Via The Motley Fool

Topics Cannabis

Finding Value In Mid-Cap Stocks ↗

June 24, 2021

Within the mid-cap space there is something for everyone.

Via Talk Markets

New Cannabinoid-Based Drug Candidates from Artelo Biosciences Show Promise as Cancer and Mental Health Treatments; Key Data Due Before Year End ↗

June 24, 2021

The following article is sponsored by the clinical communications unit of Redington, Inc. The information contained in this article in no way represents investment advice or...

Via Benzinga

14 Biotech Stocks To Watch Over The Next 6 Months ↗

June 23, 2021

Biotechs are at the mercy of several make-or-break catalysts that invariably have a big impact on stocks. A case in point was the strong upside in Biogen Inc.'s (NASDAQ:...

Via Benzinga

10 Biggest Price Target Changes For Tuesday ↗

June 22, 2021

Goldman Sachs lowered Casey's General Stores, Inc. (NASDAQ:

Via Benzinga

10 Health Care Stocks Showing Unusual Options Activity In Today's Session ↗

June 21, 2021

This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the market estimation of an option diverges away...

Via Benzinga

10 Biggest Price Target Changes For Monday ↗

June 21, 2021

SVB Leerink raised Natera, Inc. (NASDAQ:NTRA) pr...

Via Benzinga

10 Biggest Price Target Changes For Friday ↗

June 18, 2021

Piper Sandler raised Adobe Inc. (NASDAQ: ADBE) price target from $570 to $600. Adobe shares rose 3.3% to $569.50 in pre-market trading. SVB Leerink boosted Jazz...

Via Benzinga

Jazz Pharmaceuticals Updates 2021 Guidance To Include GW Pharma Acquisition ↗

June 17, 2021

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) has updated its full-year 2021 financial guidance to incorporate the GW Pharmaceuticals business, which the company...

Via Benzinga

The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO ↗

June 16, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 15) Apellis Pharmaceuticals,...

Via Benzinga

The Daily Biotech Pulse: Vertex Shelves Mid-Stage Study, Precigen & Novan Jump On Data, Hematology Conference, Janux Debuts ↗

June 11, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 10) Alexion Pharmaceuticals,...

Via Benzinga

The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda ↗

June 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 14) Alkermes plc (NASDAQ: ALKS...

Via Benzinga

The Daily Biotech Pulse: US To Procure 500M Pfizer-BioNTech Vaccine Doses For Donation, Verona Out-Licenses COPD Drug, Nautilus Lists Through SPAC Deal ↗

June 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 9) Aethlon Medical, Inc. (...

Via Benzinga

Cannabis investors Discuss Strategies For 2021 In The Context Of Consolidation And Interstate Commerce ↗

June 09, 2021

2021 seems to be the year of cannabis, as its prospects and apparent societal acceptance have dramatically changed since the industr...

Via Benzinga

Topics Cannabis

Rapid Development of Cannabinoid Based Medicinal Products Reaching New Levels

June 08, 2021

Via FinancialNewsMedia

Topics Cannabis Economy

6 Mid-Cap Gems for Growth at a Reasonable Price ↗

June 04, 2021

A look at 6 attractively valued mid-cap stocks that are trading at valuations that are lower than their expected long-term growth rates.

Via Talk Markets

Agentix Corp. (AGTX) Signs Deal With NHRI To License CBD-Based Compound To Treat Type 2 Diabetes; Adds Catalyst To Back Half Of 2021

June 02, 2021

Via AB Newswire

Topics Intellectual Property

The Daily Biotech Pulse: Pfizer In Vaccine Supply Talks With India, Provention In Focus Ahead Of Briefing Doc, NeuroRx To List Via SPAC Deal ↗

May 25, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 24) Bristol-Myers Squibb Company...

Via Benzinga

This Could Be The Most Exciting Healthcare Development Of The Year

May 21, 2021

Via FinancialNewsMedia

Topics Artificial Intelligence Cannabis

Medical Stocks Jazz, Horizon Are Accelerating But Iqvia Is Hitting The Brakes ↗

May 17, 2021

Jazz Pharmaceuticals and Horizon Therapeutics are among a cadre of accelerating medical stocks, while big names like Iqvia Holdings are hitting the brakes.

Via Investor's Business Daily

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.